Old red dye shows promise as new cancer foe Modern cancer drugs supercharge immune systems, target specific gene mutations and pack modified viruses into vaccines.
Hungarian mummy offers clues to cancer mystery Mummies have long offered up a wealth of medical information, from the role that diet plays in heart disease to the ancient origins of tuberculosis.
Evidence on talc cancer risk differs for jurors, researchers A U.S. jury verdict linking regular use of Johnson & Johnson talcum powder to a woman's death from ovarian cancer has spurred new concern from consumers, but scientists say the evidence of real danger is inconclusive at best.
Pancreatic cancer actually 4 separate diseases, researchers say An international team of researchers who carried out detailed analysis of DNA disruption, gene expression and molecular pathways in tumors concluded that pancreatic cancer is actually four separate diseases, each with a different genetic trigger and treatment, Medical News Today reported.
Doctors remove 35-pound tumor from woman's stomach that grew over 14 years When Irianita Rojas was 8 years old, a cancerous tumor started growing in her abdomen.
Researchers use skin cells to kill cancer Pharmacy researchers at the University of North Carolina at Chapel Hill have turned skin cells into cancer-hunting stem cells that destroy brain tumors— a first for medical science.
Johnson & Johnson ordered to pay $72M for cancer death linked to talcum powder Johnson & Johnson was ordered by a Missouri state jury to pay $72 million of damages to the family of a woman whose death from ovarian cancer was linked to her use of the company's talc-based Baby Powder and Shower to Shower for several decades.
Pregnant mom of 5 diagnosed with brain cancer A New York family of four was preparing to celebrate the adoption of three girls and an impeding pregnancy last Christmas when Kim Vaillancourt began suffering from a terrible headache.
More PET scans may not help lung, esophageal cancer survivors Getting expensive radioactive imaging tests to see if a cancer of the lung or esophagus has recurred is not linked to better survival, according to a new study.
FDA approves Lilly's lung cancer drug The U.S. Food and Drug Administration on Tuesday approved Eli Lilly & Co's cancer treatment, Portrazza, in combination with two forms of chemotherapy to treat patients with advanced squamous non-small cell lung cancer.
